Search results
Results From The WOW.Com Content Network
Dihydropyridine calcium channel blockers are derivatives of 1,4-dihydropyridine that are used as L-type calcium channel blockers. [1] They are used in the treatment of hypertension.
Amlodipine is used in the management of hypertension (high blood pressure) [18] and coronary artery disease in people with either stable angina (where chest pain occurs mostly after physical or emotional stress) [19] or vasospastic angina (where it occurs in cycles) and without heart failure.
Some CCBs can also cause a fast heart rate as a result of the low blood pressure. [4] Other symptoms may include nausea, vomiting, sleepiness, and shortness of breath. [2] Symptoms usually occur in the first six hours but with some forms of the medication may not start until 24 after hours. [2] There are a number of treatments that may be ...
Amlodipine/olmesartan, sold under the brand name Azor, among others is a fixed-dose combination medication used to treat high blood pressure. [5] It contains amlodipine , as the besilate, a dihydropyridine calcium channel blocker , and olmesartan medoxomil , an angiotensin II receptor blocker .
There are several known causes of adrenergic storms; in the United States, cocaine overdose is the leading cause. [16] Any stimulant drug has the capacity to cause this syndrome if taken in sufficient doses, but even non-psychotropic drugs can very rarely provoke a reaction.
Telmisartan works by blocking the effects of angiotensin II while amlodipine works by decreasing calcium ion entry into smooth muscle and heart muscle. [2] The combination was approved for medical use in the United States in 2009. [2] The combination is on the World Health Organization's List of Essential Medicines.
Amlodipine/benazepril, sold under the brand name Lotrel among others, is a fixed-dose combination medication used to treat high blood pressure. [1] It is a combination of amlodipine , as the besilate, a calcium channel blocker , and benazepril , an angiotensin converting enzyme inhibitor . [ 1 ]
[4] [12] [14] [17] [27] Therapeutic alternatives with similar clinical performance are listed for some medicines and they may be considered for national essential medicines lists. [17] [18] The 9th Essential Medicines List for Children was updated in July 2023. [23] [28] Note: An α indicates a medicine is on the complementary list. [4] [14] [17]